Estimating Blood [Lactate] Non-Invasively
Validation of a Non-Invasive Instrument to Estimate Blood Lactate
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Madeline S Reid
- Phone Number: 507-255-0007
- Email: reid.madeline@mayo.edu
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic in Rochester
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria - Aim 1:
- Subjects must be able to provide written consent.
- Adults 18 years of age and older.
- Nonsmokers.
- No recent hospitalization (< 60 days).
- Ability to perform high-intensity exercise.
Inclusion Criteria - Aim 2:
- Subjects must be able to provide written consent to be included in the research study.
- Adults 18 years of age and older.
- Nonsmokers.
- Current ICU patient.
- Have regular blood samples taken for [lactate] measurements.
- Have one or more risk factors for sepsis.
Exclusion Criteria - Aims 1 and 2:
- History of, or active malignancy.
- History of HIV with antiretroviral treatment.
- Smokers.
- Pregnancy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Whole-body exercise in healthy adults (Aim 1)
Subjects will have blood [lactate] measurement obtained with the LabClasp device while completing an exercise stress test on a treadmill or bicycle.
|
Non-invasive device that estimates blood [lactate] from interstitial fluid via a proprietary algorithm.
The device is placed between the first and second knuckle of a finger and gently applies slight pressure to extract interstitial fluid from the skin.
Sensors within the device quickly estimate blood [lactate] and return a value to the subject via an accompanying tablet within 20 seconds.
|
|
Experimental: ICU patients susceptible to developing sepsis (Aim 2)
Subjects will have blood [lactate] measurement obtained with the LabClasp device as frequently as required for clinical purposes
|
Non-invasive device that estimates blood [lactate] from interstitial fluid via a proprietary algorithm.
The device is placed between the first and second knuckle of a finger and gently applies slight pressure to extract interstitial fluid from the skin.
Sensors within the device quickly estimate blood [lactate] and return a value to the subject via an accompanying tablet within 20 seconds.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood [lactate] during incremental exercise
Time Frame: 1 day
|
Measured via venous blood and the LabClasp
|
1 day
|
|
Blood [lactate] measurements in ICU patients
Time Frame: 1 day
|
Measured via venous blood and the LabClasp
|
1 day
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Virend Somers, Mayo Clinic
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- 21-000318
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.